A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, Scripps Research and IAVI announced Wednesday. Read More
HIV Vaccine Approach Developed by Scripps Research Succeeds in First Clinical Trial
Reading Time: < 1 minute